Position in ADCT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,942,597
-$15,612,077 QoQ
Shares Held
1,318,026
-77.4% QoQ
Ownership
1.03%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 45%
Shared 0%
None 55%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ORBIMED ADVISORS LLC holds $67,146,504 across 4 Drug Manufacturers - Specialty & Generic names.
All Filings in ADCT
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,942,597 | 1,318,026 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $20,554,674 | 5,822,854 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $23,629,404 | 5,907,351 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $15,831,700 | 5,907,351 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,415,515 | 5,968,451 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $11,877,217 | 5,968,451 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $14,281,473 | 4,533,801 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $13,641,163 | 4,316,824 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||